11,700 Shares in The Cooper Companies, Inc. $COO Acquired by Employees Retirement System of Texas

Employees Retirement System of Texas bought a new stake in shares of The Cooper Companies, Inc. (NASDAQ:COO) during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund bought 11,700 shares of the medical device company’s stock, valued at approximately $959,000.

A number of other institutional investors also recently added to or reduced their stakes in COO. Bell Investment Advisors Inc grew its stake in shares of Cooper Companies by 106.3% in the third quarter. Bell Investment Advisors Inc now owns 425 shares of the medical device company’s stock worth $29,000 after purchasing an additional 219 shares in the last quarter. CYBER HORNET ETFs LLC bought a new stake in shares of Cooper Companies during the second quarter valued at about $36,000. True Wealth Design LLC lifted its holdings in Cooper Companies by 484.8% in the fourth quarter. True Wealth Design LLC now owns 462 shares of the medical device company’s stock worth $38,000 after purchasing an additional 383 shares during the period. Cromwell Holdings LLC grew its position in Cooper Companies by 128.8% in the 4th quarter. Cromwell Holdings LLC now owns 485 shares of the medical device company’s stock valued at $40,000 after buying an additional 273 shares in the last quarter. Finally, Board of the Pension Protection Fund bought a new stake in shares of Cooper Companies during the 4th quarter worth about $41,000. Institutional investors and hedge funds own 24.39% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research analysts recently commented on the stock. Needham & Company LLC raised their price objective on shares of Cooper Companies from $99.00 to $101.00 and gave the company a “buy” rating in a research note on Friday, March 6th. William Blair raised Cooper Companies to a “strong-buy” rating in a research note on Friday, January 30th. Barclays lifted their price target on Cooper Companies from $98.00 to $103.00 and gave the company an “overweight” rating in a research report on Friday, March 6th. Citigroup dropped their price objective on Cooper Companies from $88.00 to $87.00 and set a “neutral” rating on the stock in a research note on Friday, March 6th. Finally, Wall Street Zen raised Cooper Companies from a “hold” rating to a “buy” rating in a research note on Saturday, February 28th. One analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $89.93.

Cooper Companies Trading Down 2.0%

Shares of NASDAQ:COO opened at $60.80 on Thursday. The company has a debt-to-equity ratio of 0.22, a quick ratio of 0.79 and a current ratio of 1.34. The stock has a market capitalization of $11.86 billion, a price-to-earnings ratio of 30.10, a PEG ratio of 1.60 and a beta of 0.89. The Cooper Companies, Inc. has a 1-year low of $58.89 and a 1-year high of $89.83. The company has a 50 day moving average price of $66.38 and a 200 day moving average price of $75.02.

Cooper Companies (NASDAQ:COO) last posted its quarterly earnings results on Thursday, March 5th. The medical device company reported $1.10 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.03 by $0.07. Cooper Companies had a return on equity of 10.34% and a net margin of 9.67%.The company had revenue of $1.02 billion for the quarter, compared to analysts’ expectations of $1.02 billion. During the same quarter in the prior year, the company earned $0.92 earnings per share. The firm’s revenue was up 6.2% on a year-over-year basis. Cooper Companies has set its Q2 2026 guidance at 4.580-4.660 EPS. On average, research analysts anticipate that The Cooper Companies, Inc. will post 4.62 EPS for the current fiscal year.

Cooper Companies Company Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.